(Q30885896)

27 June 2017

1 reference

title

Risk of breast cancer with progestins: critical assessment of current data (English)

1 reference

27 June 2017

Richard J Santen

1

1 reference

27 June 2017

publication date

1 November 2003

1 reference

27 June 2017

1 reference

27 June 2017

volume

68

1 reference

27 June 2017

issue

10-13

1 reference

27 June 2017

page(s)

953-964

1 reference

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Epidemiologic evidence for the increased cell proliferation model of carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Hormonal carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Rules for making human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Endogenous estrogens as carcinogens through metabolic activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Is estradiol a genotoxic mutagenic carcinogen?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Tissue-specific synthesis and oxidative metabolism of estrogens.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Does postmenopausal estrogen administration increase the risk of breast cancer? Contributions of animal, biochemical, and clinical investigative studies to a resolution of the controversy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Prevention of spontaneous tumours in female rats by fadrozole hydrochloride, an aromatase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Prevention of DMBA-induced rat mammary carcinomas comparing leuprolide, oophorectomy, and tamoxifen.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Role of progestogens in the prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Androgenic, antiandrogenic, and synandrogenic actions of progestins: role of steric and allosteric interactions with androgen receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

A possible mechanism for increased breast cell proliferation by progestins through increased reductive 17 beta-hydroxysteroid dehydrogenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Opposite effects of estrogen and the progestin R5020 on cell proliferation and GCDFP-15 expression in ZR-75-1 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

The estrogenic activity of synthetic progestins used in oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Progestin stimulation of thymidine kinase in the human breast cancer cell line T47D.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Mechanisms of growth inhibition by antiestrogens and progestins in human breast and endometrial cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Mechanisms of cyclin-dependent kinase inactivation by progestins

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Regulation of breast cancer cell cycle progression by growth factors, steroids and steroid antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Effects of progestins on the proliferation of estrogen-dependent human breast cancer cells under growth factor-defined conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Estradiol and progesterone receptors in cultured normal human breast epithelial cells and fibroblasts: immunocytochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Progesterone effect on cell growth, ultrastructural aspect and estradiol receptors of normal human breast epithelial (HBE) cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

The role of TGF-beta production in growth inhibition of breast-tumor cells by progestins.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

G protein-coupled receptor 30 is critical for a progestin-induced growth inhibition in MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Progestin and G protein-coupled receptor 30 inhibit mitogen-activated protein kinase activity in MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Oral contraceptive use influences resting breast proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

The effect of age and menstrual cycle upon proliferative activity of the normal human breast

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

The effect of hormone replacement therapy on the sensitivity of screening mammograms

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Mammographic breast density during hormone replacement therapy: differences according to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Estradiol and progesterone regulate the proliferation of human breast epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Breast cancer risk after estrogen replacement therapy: results from the Toronto Breast Cancer Study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Noncontraceptive hormone use and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Long-term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900138-7

7 January 2021

10.1016/S0039-128X(03)00138-7

Identifiers

DOI

1 reference

27 June 2017

1 reference